Recent Headlines
Within Biotechnology
Novatek Announces Addition of QSV Biologics to Prestigious List of Clients
Novatek International, known worldwide for leadership in pioneering 21 CFR Part II compliant solutions for the entire product life cycle of healthcare quality operations, is pleased to announce the addition of QSV Biologics to their prestigious list of clients. QSV Biologics, a leading contract... - April 03, 2005 - Novatek International
Baxa CEO Greg Baldwin Is Now Profiled at the Expert Information for Journalists Website and Available to Address Selected Business Topics
Greg Baldwin, Chairman and CEO of Baxa Corporation of Englewood, Colorado, is now profiled on the Expert Information For Journalists website – Expert411.com. Baxa Corp., a privately held company is a leader in serving hospital pharmacy systems for handling, packaging and administering liquid medications from oral to multi-ingredient IV. Baxa is a registered medical device manufacturer with the FDA and has sales in over 35 countries. - April 02, 2005 - Baxa Corporation
Novatek Announces Addition of LifeNet to Prestigious List of Clients
Novatek International, known worldwide for leadership in pioneering 21 CFR Part II compliant solutions for the entire product life cycle of healthcare quality operations, is pleased to announce the addition of LifeNet to their prestigious list of clients. LifeNet, the nation's largest... - April 01, 2005 - Novatek International
Baxa CEO Greg Baldwin Joins Healthprolink Board of Directors
Greg Baldwin, Chairman and CEO of Baxa Corporation of Englewood, Colorado, has joined the Board of Directors for Healthprolink of Bellevue, Washington. Baxa Corporation, a privately held company, is a leader in serving hospital pharmacy systems for handling, packaging and administering liquid medications from oral to multi-ingredient IV. Baxa is a registered medical device manufacturer with the FDA and has sales in over 35 countries. - March 30, 2005 - Baxa Corporation
Baxa Corporation Celebrates 30 Years of Product Safety and Innovation for Hospital Pharmacies
In March 1975, two entrepreneurs with experience in pharmacy sales and product development started Baxa Corporation, a medical device company focused on products that ensured patient safety. Thirty years later, the company’s first product – a dispenser dedicated to safe delivery of oral medications – is still the market leader, alongside a full line of devices and systems designed to streamline fluid drug handling, admixture and packaging activities in hospital and alternate-site pharmacies. - March 24, 2005 - Baxa Corporation
Baxa Introduces Four New Microfuse® Infusion System Administration Sets
Baxa Corporation announces the addition of four specialty administration sets to the MicroFuse® Syringe Infusion System line. These new sets incorporate a T-site for the convenient administration of coronary vasodilators during myocardial perfusion imaging. Their design resulted from customer feedback on safety and ease of administration for this specialty cardiac application. - March 17, 2005 - Baxa Corporation
Baxa Introduces New Amber Oral Dispenser Packaging For Ward And Bedside Applications
Baxa Corporation announces the release of new packaging configurations for its amber Exacta-Med(R) Oral Dispensers. Oral dispensers are syringe-like devices designed specifically to provide safe and accurate delivery of oral liquid medications, without the possibility of wrong-route administration through a patient’s IV or epidural line. Their amber coloring promotes further differentiation of oral dispensers from standard hypodermic syringes. - March 07, 2005 - Baxa Corporation
Cleanrooms: A Question & Answer Document from Baxa Corporation is Now Posted on PublicRelationsNewsroom.com for Media and Professional Access
"Understanding Cleanrooms: Answers to Frequently Asked Questions," authored by Pat Hynes, VP of Global Quality for Metro Denver-based Baxa Corporation is now posted for media and professional access on PublicRelationsNewsroom.com. The American Society of Health-System Pharmacists (ASHP) released USP 797 in January 2004 and the National Institute for Occupational Safety and Health (NIOSH) published its 2004 alert on the health risks posed to those working with hazardous drugs. - February 27, 2005 - Baxa Corporation
Baxa Corporation Expands Headquarters Facilities
Baxa Corporation announces the addition of a new building to its corporate headquarters in Metro Denver. The expansion provides a 15,000 square-foot facility accommodating the sales, marketing and technical support operations for the medical device manufacturer. Two years after the company built a state-of-the-art production facility in Englewood, Colorado, unprecedented business growth constrained the office and administration space. - February 27, 2005 - Baxa Corporation
"Understanding USP 797" and "Environmental Controls for Sterile Compounding" Technical Papers are Now Posted on PublicRelationsNewsroom.com
Two technical papers produced by Baxa Corporation – “Understanding USP 797” and “Environmental Controls for Sterile Compounding” are now posted for media and professional access on PublicRelationsNewsroom.com. The American Society of Health-System Pharmacists (ASHP) released USP 797 in January 2004 and the National Institute for Occupational Safety and Health (NIOSH) published its 2004 alert on the health risks posed to those working with hazardous drugs. - January 30, 2005 - Baxa Corporation